Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal bupivacaine versus bupivacaine + dexamethasone for superior trunk block after shoulder arthroscopy
ChiCTR2500102019Phase 4Not yet recruiting
- Sponsor
- Zhuji People's Hospital of Zhejiang Province
- Start
- May 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label trial of liposomal bupivacaine, bupivacaine and dexamethasone in postoperative pain (2 arms), sponsored by Zhuji People's Hospital of Zhejiang Province. Primary endpoint: Duration of postoperative analgesia. Planned start May 2025; status: not yet recruiting.
02
Drugs
liposomal bupivacainebupivacainedexamethasone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2500102019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500102019.